ARTICLE | Company News
ImClone completes Erbitux BLA
November 1, 2001 8:00 AM UTC
IMCL and partner Bristol-Myers (BMY) said IMCL had completed its rolling BLA submission to the FDA for Erbitux (formerly IMC-C225), an anti- EGFR monoclonal antibody to treat refractory colorectal can...